An Ebola vaccine trial has began in West Africa’s Mali according to a report published by NBC News.
The vaccine, which was developed by the US National Institutes of Health, has safely been tested on animals and is the first vaccine to undergo human trials in Africa since the latest Ebola outbreak.
Only three health care workers have been administered with the experimental vaccine as part of the Mali clinical trial, as the safety of the vaccine on humans is yet to be determined.